Retraction: Dihydroartemisinin suppresses the tumorigenesis and cycle progression of colorectal cancer by targeting CDK1/CCNB1/PLK1 signaling.
出版信息
Front Oncol. 2025 Mar 25;15:1591122. doi: 10.3389/fonc.2025.1591122. eCollection 2025.
Abstract
[This retracts the article DOI: 10.3389/fonc.2021.768879.].
摘要
相似文献
1
Retraction: Dihydroartemisinin suppresses the tumorigenesis and cycle progression of colorectal cancer by targeting CDK1/CCNB1/PLK1 signaling.
Front Oncol. 2025 Mar 25;15:1591122. doi: 10.3389/fonc.2025.1591122. eCollection 2025.
2
Dihydroartemisinin Suppresses the Tumorigenesis and Cycle Progression of Colorectal Cancer by Targeting CDK1/CCNB1/PLK1 Signaling.双氢青蒿素通过靶向CDK1/CCNB1/PLK1信号通路抑制结直肠癌的肿瘤发生和细胞周期进程。
Front Oncol. 2021 Nov 2;11:768879. doi: 10.3389/fonc.2021.768879. eCollection 2021.
3
Anti-malarial drug dihydroartemisinin downregulates the expression levels of and in liver cancer.抗疟药物双氢青蒿素下调肝癌中……和……的表达水平。 （原文中“and”前后内容缺失）
Oncol Lett. 2021 Sep;22(3):653. doi: 10.3892/ol.2021.12914. Epub 2021 Jul 9.
4
Retraction: Berberine suppresses stemness and tumorigenicity of colorectal cancer stem-like cells by inhibiting mA methylation.撤稿声明：黄连素通过抑制 mA 甲基化抑制结直肠癌干细胞样细胞的干性和致瘤性。
Front Oncol. 2024 Sep 30;14:1495458. doi: 10.3389/fonc.2024.1495458. eCollection 2024.
5
miR-96-5p Suppresses the Progression of Nasopharyngeal Carcinoma by Targeting CDK1 [Retraction].miR-96-5p通过靶向CDK1抑制鼻咽癌进展[撤回]
Onco Targets Ther. 2022 Nov 22;15:1407-1408. doi: 10.2147/OTT.S398523. eCollection 2022.
6
LINC00346 Acts as a Competing Endogenous RNA Regulating Development of Hepatocellular Carcinoma via Modulating CDK1/CCNB1 Axis.LINC00346作为一种竞争性内源性RNA，通过调节CDK1/CCNB1轴调控肝细胞癌的发展。
Front Bioeng Biotechnol. 2020 Feb 18;8:54. doi: 10.3389/fbioe.2020.00054. eCollection 2020.
7
MicroRNA-143-3p Suppresses Tumorigenesis by Targeting Catenin-δ1 in Colorectal Cancer [Retraction].微小RNA-143-3p通过靶向结直肠癌中的连环蛋白δ1抑制肿瘤发生[撤回]
Onco Targets Ther. 2023 Apr 6;16:233-234. doi: 10.2147/OTT.S415732. eCollection 2023.
8
Bioinformatics Analysis Highlight Differentially Expressed CCNB1 and PLK1 Genes as Potential Anti-Breast Cancer Drug Targets and Prognostic Markers.生物信息学分析突出差异表达的 CCNB1 和 PLK1 基因作为潜在的抗乳腺癌药物靶点和预后标志物。
Genes (Basel). 2022 Apr 7;13(4):654. doi: 10.3390/genes13040654.
9
The circular RNA circ-Ccnb1 dissociates Ccnb1/Cdk1 complex suppressing cell invasion and tumorigenesis.环状 RNA circ-Ccnb1 使 Ccnb1/Cdk1 复合物解离，抑制细胞侵袭和肿瘤发生。
Cancer Lett. 2019 Sep 10;459:216-226. doi: 10.1016/j.canlet.2019.05.036. Epub 2019 Jun 12.
10
Multi-omics insights into the roles of CCNB1, PLK1, and HPSE in breast cancer progression: implications for prognosis and immunotherapy.CCNB1、PLK1和HPSE在乳腺癌进展中的作用的多组学见解：对预后和免疫治疗的意义
Discov Oncol. 2025 Apr 5;16(1):471. doi: 10.1007/s12672-025-02282-z.
Zotero 插件